# Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

> **NCT00122564** · PHASE1 · TERMINATED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 36 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** HIV-1 gp 160
- **BIOLOGICAL:** DC-Chol

## Key facts

- **NCT ID:** NCT00122564
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 36 (—)
- **Last updated:** 2005-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122564, "Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00122564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*